Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial
JAMA Oncol. 2025 Oct 16. doi: 10.1001/jamaoncol.2025.4125. Online ahead of print. ABSTRACT IMPORTANCE: Cribriform prostate cancer is associated with poor outcomes; however, its optimal treatment …